Joo-young Yang
Ilsan, Republic of Korea
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Comparison of Resolute zotarolimus-eluting and Xience everolimus-eluting stents in patients with de novo long coronary artery lesions: a randomized LONG-DES VI trial.
Journal: Coronary artery disease
Published: December 04, 2018
Response to letter regarding article, "optimal duration of dual antiplatelet therapy after drug-eluting stent implantation: a randomized, controlled trial".
Journal: Circulation
Published: December 03, 2014
Randomized Comparisons Between Different Stenting Approaches for Bifurcation Coronary Lesions With or Without Side Branch Stenosis.
Journal: JACC. Cardiovascular interventions
Published: October 01, 2014
Comparison of biolimus A9-eluting (Nobori) and everolimus-eluting (Promus Element) stents in patients with de novo native long coronary artery lesions: a randomized Long Drug-Eluting Stent V trial.
Journal: Circulation. Cardiovascular interventions
Published: May 15, 2014
Comparison of resolute zotarolimus-eluting stents and sirolimus-eluting stents in patients with de novo long coronary artery lesions: a randomized LONG-DES IV trial.
Journal: Circulation. Cardiovascular interventions
Published: October 11, 2012
Outcomes after unrestricted use of everolimus-eluting and sirolimus-eluting stents in routine clinical practice: a multicenter, prospective cohort study.
Journal: Circulation. Cardiovascular interventions
Published: June 14, 2012
Impact of positive peri-stent vascular remodeling after sirolimus-eluting and paclitaxel-eluting stent implantation on 5-year clinical outcomes: intravascular ultrasound analysis from the Poststent Optimal Stent Expansion Trial multicenter randomized trial.
Journal: Circulation journal : official journal of the Japanese Circulation Society
Published: March 03, 2012
Evaluation of the dose-response relationship of amlodipine and losartan combination in patients with essential hypertension: an 8-week, randomized, double-blind, factorial, phase II, multicenter study.
Journal: American journal of cardiovascular drugs : drugs, devices, and other interventions
Published: January 06, 2012
Showing 1-8 of 8
Last Updated: 09/26/2026